Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve Audited Standalone and ....
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Ltd has informed the stock exchanges that its Board of Directors will meet on Monday, 19 May 2025. The main agenda is to consider and approve the audited Standalone and Consolidated Financial Results for the quarter and full year ended 31 March 2025. As per insider trading rules, the trading window for the company's shares has been closed since 1 April 2025 and will reopen 48 hours after the results are publicly disclosed. The intimation has been signed by Managing Director Mukund Mehta.
This is a routine procedural filing with no material impact. Investors should watch for the actual audited results on or after 19 May 2025, which will reveal the company's full-year performance and could be a stock-moving event.